Fructo-oligosaccharides and Irritable Bowel Syndrome

Beghin-Meiji60 enrolled

Overview

Fructo-oligosaccharides are known as prebiotic ingredients to modulate the composition of the intestinal microbiota and particularly to stimulate the growth of Bifidobacteria. Imbalance of the intestinal microbiota such as reduction of Bifidobacteria is implicated in Irritable Bowel Syndrome (IBS). Thus the objective of the study is to evaluate the effect of fructo-oligosaccharides to improve IBS score and to explore which modifications of the microbiota are responsible of this improvement.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Enrollment

Conditions

Irritable Bowel Syndrome

Interventions

Fructo-oligosaccharidesDIETARY_SUPPLEMENT

Dietary supplementation for 4 weeks

MaltodextrinsDIETARY_SUPPLEMENT

Dietary supplementation for 4 weeks

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * IBS subjects according to Rome III criteria * Incomfort below or equivalent to 30mmHg during Tensostat test * between 18 and 60 years * no antibiotic treatment for the last 2 months * less than 20g of dietary fibres consummed per day * no analgesic treatment * no treatment for intestinal transit Exclusion Criteria: * subjects suffering from diabetes, colic cancer, inflammatory bowel disease, dysthyroidy, Hirschprung disease, anorexia * excessive consumption of alcohol or tobacco * participating to another clinical study * pregnant women * antidepressor or anxiolytic treatment

Locations (2)

CHU Clermont Ferrand

Clermont-Ferrand, France

Vall Hebron Hospital

Barcelona, Spain

Outcomes

Primary Outcomes

rectal sensitivity

Time frame: 4 weeks

Secondary Outcomes

taxonomic composition of intestinal microbiota

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.